Company news
Genomtec Sa (GPW:GMT) news
Genomtec Sa news releases on 6ix. Latest, Jun 1, 2026: GMT: Net loss narrowed and revenue rose, but continued funding and market risks persist
Press releases & updates
GMT: Net loss narrowed and revenue rose, but continued funding and market risks persist
June 1, 2026
GMT: Patent expansion, cost cuts, and narrowed loss set the stage for commercialization in 2026
April 30, 2026
GMT: Net loss persists as R&D spending rises; commercialization and funding remain critical
November 28, 2025
GMT: Net loss deepened to PLN 6.6M as R&D spending rose; commercialization still ahead
September 29, 2025
GMT: Genomtec's Q1 2025 loss widened as R&D ramped up, with commercialization still pending
May 29, 2025
GMT: Rapid genetic diagnostics, strong IP, and robust funding drive growth and M&A momentum
May 14, 2025
GMT: Net loss widened to PLN -11.2m as R&D continued, with equity raises ensuring 12+ months liquidity
April 29, 2025
GMT: Genomtec accelerates M&A, slashes production costs, and strengthens its position in diagnostics
December 11, 2024
GMT: Losses persist as Genomtec advances R&D, secures funding, and pursues M&A for commercialisation
November 29, 2024
GMT: Net loss widened to PLN 6.0 million in H1 2024 as Genomtec advanced R&D and raised new capital
September 26, 2024